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Summary
Obtaining complete protein inventories for subcellular regions is a challenge that often limits our 
understanding of cellular function, especially for regions that are impossible to purify and are 
therefore inaccessible to traditional proteomic analysis. We recently developed a method to map 
proteomes in living cells with an engineered peroxidase (APEX) that bypasses the need for 
organellar purification when applied to membrane-bound compartments; however, it lacked 
specificity when applied to unbounded regions that allow APEX-generated radicals to escape. 
Here, we combine APEX technology with a SILAC-based ratiometric tagging strategy to 
substantially reduce unwanted background and achieve nanometer spatial resolution. This is 
applied to map the proteome of the mitochondrial intermembrane space (IMS), which can freely 
exchange small molecules with the cytosol. Our IMS proteome of 127 proteins has >94% 
specificity and includes nine novel mitochondrial proteins. This approach will enable scientists to 
map proteomes of cellular regions that were previously inaccessible.
Introduction
Cell biologists strive to obtain complete protein lists for the subcellular regions they are 
studying, but using traditional mass spectrometry (MS)-based proteomics, this is only 
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possible for cellular compartments that can be isolated in high yield and purity. Because 
many cellular regions are difficult or impossible to purify, their proteomes are unknown or 
incompletely known. To address this challenge, we developed a method to map specific 
proteomes in living cells using an engineered ascorbate peroxidase (APEX) (Martell et al., 
2012; Rhee et al., 2013). As shown in Figure 1A, APEX is first genetically targeted to the 
cellular compartment of interest. Then, upon addition of the small molecule biotin-phenol 
and hydrogen peroxide (H2O2), APEX covalently tags surrounding endogenous proteins 
with the biotin-phenoxyl radical oxidation product during a one minute window. 
Subsequently, cells are lysed, and biotinylated proteins are isolated with streptavidin beads 
and identified by MS.
Previously, we used APEX to map the proteome of the human mitochondrial matrix (Rhee 
et al., 2013). In this study, we focused on the proteome of the mitochondrial intermembrane 
space (IMS), which lies between the inner mitochondrial membrane (IMM) and outer 
mitochondrial membrane (OMM) (Fig. 1A). The IMS cannot be purified by traditional 
approaches such as density centrifugation. This compartment is associated with many 
essential functions, including apoptosis, protein import and folding, and reactive oxygen 
species detoxification (Bonora et al., 2012; Herrmann and Riemer, 2010; Taanman, 1999), 
yet it is much less well-understood than the mitochondrial matrix.
In addition to its biological importance, the IMS presents a major technical challenge for the 
APEX methodology. Unlike the mitochondrial matrix, the IMS is not fully membrane-
enclosed. Although the IMM blocks the passage of APEX-generated biotin-phenoxyl 
radicals into the matrix (Rhee et al., 2013), the OMM contains porins that allow free 
exchange of molecules <5 kD between the cytosol and IMS (Herrmann and Riemer, 2010). 
Thus, IMS-targeted APEX could potentially biotinylate cytosolic proteins outside the 
mitochondria, giving unwanted background (Fig. 1A). Here, we develop a stable isotope 
labeling by amino acids in cell culture (SILAC)-based ratiometric tagging strategy that 
effectively excludes cytosolic proteins and produces a highly specific proteomic map of the 
human IMS.
Results
IMS-APEX labeling in cells characterized by imaging and western blotting
We targeted APEX to the IMS of HEK 293T cells by fusing it to the 68-amino acid leader 
sequence of the native IMS serine beta-lactamase-like protein LACTB (Polianskyte et al., 
2009) and confirmed correct localization by electron microscopy (EM) (Martell et al., 2012) 
(Fig. 1B). Next, transfected cells were labeled live with H2O2 for 1 minute in the presence 
of pre-incubated biotin-phenol, then lysed and analyzed by gel electrophoresis and 
streptavidin blot to detect biotinylated proteins. Figure 1C shows that IMS-APEX 
biotinylates many proteins in a banding pattern that differs from that produced by a cytosolic 
APEX variant. This suggests that IMS-APEX and cytosolic APEX tag different endogenous 
proteomes, as expected.
Biotin labeling by IMS-APEX was also assessed by imaging. After live cell labeling for 1 
minute, samples were fixed and stained with neutravidin-AlexaFluor647 to visualize 
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biotinylated proteins. Figure 1D shows a diffuse biotin staining pattern that extends well 
beyond mitochondria, even though IMS-APEX is cleanly localized to mitochondria (Fig. 
S1A). In contrast, the localization of mitochondrial matrix-APEX overlaps tightly with the 
proteins it biotinylates. This suggests that, in the case of IMS-APEX labeling, either the 
APEX-generated biotin-phenoxyl radicals diffuse far beyond the OMM (through porins), 
and/or that molecules biotinylated by IMS-APEX subsequently diffuse out of mitochondria 
during the 1 minute labeling window to give a diffuse pattern.
To distinguish between these two possibilities, we developed a western blot assay. We 
harvested proteins biotinylated by IMS-APEX using streptavidin beads and probed this 
enriched material for the presence of both IMS and cytosolic markers. Figures S1B–E show 
that IMS-APEX biotinylates the endogenous IMS protein apoptosis-inducing factor (AIF) in 
addition to a co-transfected IMS marker (LACTB-myc-Y5-YFP-Y5). A co-transfected 
cytosolic marker (mCherry-Flag-LplA) is biotinylated by IMS-APEX to a much lesser 
extent. In the converse experiment, we found that cytosol-localized APEX strongly 
biotinylates the Flag-tagged cytosolic marker but gave much weaker biotinylation of the two 
IMS proteins. These results suggest that the APEX labeling radius is indeed limited, and the 
diffuse neutravidin staining observed in Figure 1D may result from re-localization of biotin-
tagged proteins and other molecules, rather than long-range diffusion of the biotin-phenoxyl 
radical. To more rigorously investigate the spatial specificity of labeling, however, we 
proceeded to a MS proteomic experiment.
Initial proteomic experiment produces high cytosolic background
For our first attempt, we used an experimental setup identical to that of our APEX 
mitochondrial matrix study (Rhee et al., 2013). The experimental samples were grown in 
SILAC media (Ong et al., 2002) containing heavy isotopes of arginine and lysine, whereas 
the control samples were grown in light SILAC media (Fig. S2A). More than 4,000 proteins 
were detected by MS in each of two independent replicates. Protein SILAC ratios are plotted 
in histograms in Figures S2D–E. Encouragingly, true positive and false positive analyses 
show that the right ends of the histograms (proteins with high heavy/light, or H/L, SILAC 
ratios) are enriched for known IMS proteins, whereas the left ends (low H/L) contain 
predominantly non-mitochondrial proteins.
We produced a list of 362 entries by retaining only proteins with high H/L in both replicates 
(row 1 of Fig. 2D). The mitochondrial specificity was calculated as the fraction of proteins 
in this list with prior mitochondrial annotation (40%). Depth of coverage was determined by 
generating a list of 75 well-established IMS proteins (“IMS gold+ list”, tab 1 of Table S2) 
and calculating the fraction of this list present in our proteome (69%). Both specificity and 
coverage values are much lower than those previously obtained in our mitochondrial matrix 
study (>94% and ~85%, respectively) (Rhee et al., 2013). We found that by raising the H/L 
cutoff (row 2 of Fig. 2D), we could increase specificity to 58% at the expense of coverage 
(49%). These numbers indicate that this dataset cannot be used to generate an IMS proteome 
of acceptable quality.
Examining the data more closely, we found that high H/L proteins include cytosolic proteins 
that reside near mitochondria, such as kinesin and microtubule-associated proteins. We 
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interpret this to mean that (1) the porosity of the OMM, as feared, permits IMS-APEX-
generated biotin-phenoxyl radicals to escape the IMS and biotinylate cytosolic proteins, and 
(2) SILAC ratio magnitude reflects not only proximity to APEX but likely other factors as 
well, such as steric accessibility and surface tyrosine count, explaining why some detected 
cytosolic proteins have higher H/L ratios than bona fide IMS proteins. Given these factors, it 
was necessary to develop a new approach to using APEX for proteomic mapping with high 
spatial specificity.
Ratiometric APEX tagging yields a high-quality IMS proteome
In the field of fluorescent reporters, absolute fluorescence intensity in a cell can be affected 
by many factors other than the specific parameter of interest (e.g., phosphorylation or Ca2+ 
concentration), such as local variations in reporter concentration (Mehta and Zhang, 2011). 
To address this problem, many reporters are designed to be ratiometric, such that the 
emission ratio of two fluorophores reads out the desired parameter and is independent of 
other factors such as reporter concentration (Bootman et al., 2013; Ting et al., 2001). We 
sought to apply a similar concept to APEX tagging (Fig. 2A). Instead of only measuring the 
extent of a protein’s biotinylation by IMS-APEX (via its H/L SILAC ratio), we sought to 
measure the ratio of its biotinylation extent by two different APEX constructs: one inside the 
region of interest (e.g., IMS-APEX) and one outside the region of interest (e.g., cytosolic 
APEX). This ratio-based strategy would address both of the problems described above. First, 
even if biotin-phenoxyl radicals escape beyond the OMM, it should be possible to 
distinguish IMS-resident proteins from cytosolic proteins just outside mitochondria by the 
ratio of their biotinylation extents by IMS-APEX versus cytoslic APEX. This is because an 
IMS-resident protein should be more extensively labeled by IMS-APEX than by cytosolic 
APEX, and the reverse should be true for a cytosol-resident protein. Second, this ratio 
should reflect only proximity to the IMS (or cytosol) and no other factor such as steric 
accessibility because such factors should equally affect IMS-APEX labeling and cytosolic 
APEX labeling of the same protein and therefore be cancelled out.
To implement this ratiometric approach, we established three rather than two SILAC 
cultures: a heavy culture (H) that was labeled with IMS-APEX, a medium culture (M) that 
was labeled with a cytosolic APEX construct (APEX-NES, where NES is a nuclear export 
signal), and a light culture (L) that was a negative control with APEX omitted (Fig. 2B). 
While H/L and M/L ratios reflect biotinylation extent by IMS-APEX and APEX-NES, 
respectively, the H/M ratio reflects the extent to which a protein is preferentially 
biotinylated by IMS-APEX versus APEX-NES.
More than 4,800 proteins were detected by MS, each associated with three SILAC ratios: 
H/L, M/L, and H/M. In Figure 2C, each detected protein is plotted by its log2(H/L) ratio 
(reflecting extent of biotinylation by IMS-APEX) on the y-axis and by its log2(M/L) ratio 
(reflecting extent of biotinylation by APEX-NES) on the x-axis. Two major populations are 
visible: one with a negative slope in the top left quadrant and one with a slightly positive 
slope in the top right quadrant. The first population is enriched in known IMS proteins (from 
our IMS gold+ list, tab 1 of Table S2), which are colored in green, and the second 
population contains mostly proteins that lack mitochondrial annotation, which are colored in 
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red. This result is consistent with our experimental design because the top left quadrant 
contains proteins with higher H/L ratios and lower M/L ratios, i.e., high H/M ratios, 
reflecting greater biotinylation by IMS-APEX than by APEX-NES.
To filter these data and define our IMS proteome, we calculated the optimal SILAC ratio 
cut-offs that maximize the difference between the true positive rate and the false positive 
rate (Fig. S2F). Interestingly, the application of a cut-off based on H/M alone produced a list 
of 237 proteins whose mitochondrial specificity was 72% and whose coverage of known 
IMS proteins was 68% (row 3 of Fig. 2D). These values are already much improved 
compared to those obtained using our original 2-state SILAC approach. When we filtered 
the data using H/L ratio as well to exclude proteins without biotinylation signal above 
background, the mitochondrial specificity increased to 80%, and the coverage dropped by 
only 1% to 67%. For our final IMS proteomic list of 127 proteins (row 5 of Fig. 2D), we 
retained proteins with both high H/M from the 3-state experiment and high H/L from both 
replicates of our 2-state SILAC experiments. The mitochondrial specificity of this list was 
87%, and its coverage of known IMS proteins was 65%. These numbers are dramatically 
improved compared to those obtained with IMS-APEX labeling alone and approach the 
values for our previous matrix proteome (Rhee et al., 2013).
Characterizing the specificity of the IMS proteome
Figure 3A shows that 87% of the IMS proteome contains proteins with prior mitochondrial 
annotation. 13%, or 16 proteins, do not have previous connections to mitochondria 
(mitochondrial “orphans” in tab 2 of Table S2). These could be false positives or newly 
discovered mitochondrial proteins. We performed fluorescence imaging of 6 of these 
proteins and observed partial or complete overlap with a mitochondrial GFP marker (Fig. 
3C). Three additional proteins were detected by western blotting analysis of purified mouse 
mitochondria (Fig. 3D). These data raise the actual mitochondrial specificity of the IMS 
proteome from 87% to 94%. Notably, we also performed imaging and/or western blot 
analysis of three additional mitochondrial orphans (RCN2, P4HB, and CCSMST1) but did 
not obtain evidence of mitochondrial localization. These proteins could represent erroneous 
detections, or they could be present in such low amounts in mitochondria that our 
fluorescence and western blot assays do not have the sensitivity to detect them.
To analyze the specificity of the proteomic dataset for IMS proteins in particular, as opposed 
to proteins in other regions of mitochondria, we first considered the fact that IMS-APEX 
could potentially tag any IMS-exposed protein, including OMM and IMM proteins. We 
therefore calculated the fraction of proteins in the IMS proteome with IMS, OMM, or IMM 
annotation as opposed to matrix annotation. This was 99%, compared to 74% for all 
mitochondrial proteins that have sub-mitochondrial annotation (Fig. 3A). Our IMS proteome 
is therefore enriched in potentially IMS-exposed proteins.
We also analyzed IMS specificity by examining the components of the TOM/TIM/PAM 
mitochondrial protein import complex, whose subunits have well-characterized topologies 
(Bolender et al., 2008; Gebert et al., 2011; Neupert and Herrmann, 2007). Figure 3B shows 
that only IMS-exposed subunits of this complex are detected in the IMS proteome. This is 
strikingly complementary to our detection of matrix-exposed subunits in our previous matrix 
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proteome (Rhee et al., 2013). We performed a similar analysis of Complexes I–V of the 
electron transport chain (Fig. S3A). Most of the subunits we detected in the IMS proteome 
are known to be IMS-exposed. One exception was F6 of Complex V (ATP synthase), which 
was highly enriched in the IMS proteome, and absent from our previous matrix proteome 
(Rhee et al., 2013). Follow-up EM analysis (Fig. S3B) showed F6-APEX2 staining in the 
matrix only, suggesting that our detection of endogenous F6 in the IMS is erroneous or a 
small population of F6 exists in the IMS that is not visible by EM.
Finally, IMS specificity can be examined via the biotinylated peptides that we detected, 
which reveal the exact site of labeling by the biotin-phenoxyl radical. Such peptides were 
identified for 47 of our 127 IMS proteins (tab 3 of Table S1). Of these 47 proteins, 14 are 
transmembrane IMM proteins with known or predicted topologies. The 24 biotinylated 
peptides derived from these 14 proteins all map to IMS-facing rather than matrix-facing 
domains (column S in tab 3 of Table S1). 3 of these 14 transmembrane IMM proteins 
(APC1, NDUFB6, and UQCRQ) had biotinylated peptides detected in the matrix proteomic 
experiment (Rhee et al., 2013) as well (column T in tab 3 of Table S1). The 3 sites 
biotinylated by matrix-APEX map exclusively to matrix-exposed sides (Arco and 
Satrústegui, 2004; Gao et al., 2002; Murray et al., 2003) (Fig. S3C). Our observations 
reinforce the notion that biotin-phenoxyl radicals do not cross the IMM and suggest that 
APEX labeling can be used to help unravel the topology of membrane proteins within living 
cells.
Analysis of specific proteins within the IMS proteome
The IMS proteome provides some novel insights and raises numerous hypotheses, 
particularly when combined with our previous mitochondrial matrix proteome. First, as 
described above, we have identified 9 novel mitochondrial proteins that we validated by 
imaging or western blotting. These include three endoplasmic reticulum (ER)-associated 
proteins (FKBP10, MGST3, and STX17), a lipid transport protein (APOO), a mitotic 
regulator (CDC25C), an autophagy receptor (NBR1), and three proteins of unknown 
function (A8MTT3, C1orf163, and CCDC127). We were especially intrigued by the ER-
annotated proteins because of the great interest in mitochondria-ER communication and 
contact sites (Kornmann and Walter, 2010). One of our mitochondrial orphans, syntaxin 17 
(Stx17), is a transmembrane SNARE-type protein that has been observed at mitochondria-
ER contact sites during autophagy (Hamasaki et al., 2013). However, its localization under 
basal conditions is unclear. Hamasaki et al. observed Stx17 solely on ER membranes 
(Hamasaki et al., 2013), but Itakura et al. reported cytosolic and mitochondrial pools as well 
(Itakura et al., 2012). To further examine the localization of Stx17 and reconcile our data 
with previous literature, we performed EM imaging of an APEX2 (Lam et al., submitted) 
fusion to Stx17. DAB stain was clearly observed on the OMM facing the cytosol, but we 
also found fields of view displaying the strongest staining at mitochondria-ER contact sites 
(Fig. 4A). This result supports partial mitochondrial localization of Stx17 (with the loop 
between transmembrane domains contacting the IMS, as shown in Fig. 4B) and suggests a 
role in mitochondria-ER communication, even in non-autophagic cells.
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Second, the IMS proteome gives insight into mitochondrial proteins whose sub-
mitochondrial localizations are unknown or under debate. Our data suggest that 21 proteins 
without prior sub-mitochondrial localization data have IMS-exposed regions (tab 3 of Table 
S2). Furthermore, our data shed light on MICU1, a calcium-binding protein that regulates 
the function of the mitochondrial calcium uniporter (MCU), the channel in the IMM that 
allows mitochondria to uptake calcium from the cytosol (Perocchi et al., 2010). The 
mechanism by which MICU1 regulates MCU is unclear partly because of conflicting 
evidence regarding MICU1’s sub-mitochondrial localization. One study used protease 
accessibility assays on purified mitochondria to show that MICU1 resides in the IMS 
(Csordás et al., 2013), where it is able to sense changes in cytosolic Ca2+ levels. However, 
another study used live cell fluorescence imaging to conclude that MICU1 resides in the 
matrix (Hoffman et al., 2013), which is shielded from cytosolic Ca2+ changes by the IMM. 
Mallilankaraman et al. have proposed a mechanistic model for MICU1 regulation that relies 
on its residence in the matrix (Mallilankaraman et al., 2012), and this model conflicts with 
that of Csordás et al., which assumes that MICU1 resides in the IMS (Csordás et al., 2013). 
These differing conclusions reflect the imperfect nature of the assays used to determine 
MICU1 sub-mitochondrial localization. For example, these assays can be affected by lysis 
of purified mitochondria, or overexpression and tag interference with MICU1 function.
In contrast, our proteomic data report on endogenous, untagged proteins in intact 
mitochondria within living cells. MICU1 was detected in our IMS proteome, but not in our 
matrix proteome (Rhee et al., 2013) (Fig. 4C). Interestingly, MICU2, a related protein with 
non-redundant function (Kamer and Mootha, 2014), was also detected in the IMS proteome 
but not in the matrix proteome (Rhee et al., 2013). Therefore, the IMS and matrix proteomic 
data together are consistent with MICU1 and MICU2 localization in the IMS. These 
observations will help to develop a mechanistic model for its regulatory behavior.
Third, a novel set of hypotheses emerge when we cross our IMS proteome with our previous 
matrix proteome (Rhee et al., 2013). As discussed above, APEX-generated biotin-phenoxyl 
radicals do not cross the IMM. Hence, a protein that is detected in both IMS and matrix 
proteomes is likely to be either a dual-localized protein, or a transmembrane IMM protein. 
33 proteins were found in both proteomic lists (tab 6 of Table S2), and of these, 19 are 
known to be transmembrane IMM proteins (e.g., SCO1 (Horng et al., 2005) and LETM1 
(Tamai et al., 2008)). One protein, HSPE1, is known to be dual-localized (Samali et al., 
1999). The remaining 13 proteins are potentially novel transmembrane IMM or IMS/matrix 
dual-localized proteins that warrant further investigation.
Discussion
APEX is a powerful technology for tagging endogenous proteomes in living cells, but a 
major question raised by our previous study, which mapped the mitochondrial matrix 
proteome (Rhee et al., 2013), is whether or not this method has the spatial specificity to map 
cellular regions that are not membrane-enclosed. We have addressed this question by 
mapping the proteome of the mitochondrial IMS. Unlike the matrix, the IMS is “leaky” 
because the outer mitochondrial membrane contains porins that allow free passage of 
molecules <5 kD in size (Herrmann and Riemer, 2010). APEX-generated biotin-phenoxyl 
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radicals (<0.4 kD) could thus potentially diffuse out of the IMS to give unwanted tagging of 
cytosolic proteins.
In this study, we showed that the original approach cannot produce a specific map of the 
IMS because APEX-generated radicals tag cytosolic proteins just outside mitochondria and 
produce significant background signal. Therefore, we developed a new methodology based 
on ratiometric tagging of endogenous proteins by APEX in the IMS versus APEX in the 
cytosol, followed by data filtering based on ratio magnitude. This new approach was able to 
produce a high-quality IMS proteome of 127 proteins with >94% specificity and 65% 
coverage. We note that our ratiometric approach has some resemblance to previous 
approaches (Dunkley et al., 2004; Foster et al., 2006) used to improve specificity of 
proteomic mapping of purified ER and Golgi.
Though demonstrated only for the IMS here, we expect the ratiometric APEX tagging 
approach to be generalizable to other cellular regions as well. This technique should always 
be used with a quantitative proteomic method such as SILAC or iTRAQ (isobaric tag for 
relative and absolute quantitation). Our study shows that although biotin-phenoxyl radical 
concentrations may fall off rapidly, proteins that are tens to hundreds of nanometers away 
(e.g., beyond the OMM, which is ~5 nm thick) may still be detectably biotinylated; hence, in 
the absence of an impermeable membrane barrier, the mere presence of a biotin label is not 
evidence of close proximity to APEX. The ratio of two experimental samples, one with 
APEX in the region or macromolecular complex of interest, and the other with APEX 
outside the region or complex (as we did here, with IMS-APEX and APEX-NES), best 
reflects proximity to APEX.
The methodology has some important limitations. One is that coverage is not high. We 
suspect that the main factor limiting coverage is steric accessibility of modifiable amino acid 
side chains (e.g., tyrosine) to the biotin-phenoxyl radical. Since labeling is performed in live 
cells, macromolecular complexes are still intact, which will fundamentally limit the 
accessibility of sterically hindered proteins to the biotin probe. We are also interested in 
exploring new labeling chemistries that can target a broader array of side chains.
Second, because the APEX radical chemistry results in chemically heterogeneous adducts of 
unknown masses, we currently have limited ability to determine the exact residues tagged by 
the biotin-phenol probe. This information could have great value, for instance for 
determining the topology of membrane proteins. Improvements in the labeling chemistry 
and development of peptide-enrichment strategies should allow us to map biotinylation sites 
much more extensively than is currently possible.
A third limitation to the method is that specificity, though high in this case, is not perfect. 
For our IMS proteome, 7 proteins were identified that we and others could not validate as 
true mitochondrial proteins. They may be present in the IMS in very low amounts. 
Alternatively, since 5 of these are known to be ER or secretory pathway proteins (RCN2, 
P4HB, NUCB2, TXNDC12 and LAMC1), and the IMS and ER may be physically linked 
(Chandra et al., 1998), perhaps biotin-phenoxyl radicals generated in the IMS leak into the 
ER to tag endogenous proteins there. Our ratiometric SILAC experiment with APEX-NES 
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would not have excluded this background, but a future experiment with IMS-APEX labeling 
ratioed against APEX-ER labeling should be able to.
Finally, our approach has the problem of potentially missing dual-localized proteins. For 
example, a protein that has both an IMS and a cytosolic population would be filtered out 
based on low H/M ratio. We did generate a separate table of 33 proteins that have high H/L 
ratios, but only moderate H/M ratios (tab 2 of Table S1); however, these would need to be 
screened one by one to determine if both IMS and cytosolic pools truly exist (or if they are 
transmembrane OMM proteins).
Recently, Vögtle et al. mapped the proteome of the yeast IMS by a different approach 
(Vögtle et al., 2012). Purified mitochondria were treated with the apoptotic factor Bax to 
trigger permeabilization of the outer mitochondrial membrane. SILAC was then used to 
determine which IMS proteins were lost following this treatment. Compared to our 
approach, the main disadvantages are the reliance on purified mitochondria (which can 
introduce artifacts, such as the background efflux of matrix proteins observed over time in 
this study), the lack of detection of membrane-associated proteins that do not dissociate after 
Bax treatment (for example, an analogous study in mammalian cells would fail to detect 
MICU1 because it remains tightly associated with MCU in the IMM (Sancak et al., 2013)), 
and the inability to generalize the approach to species that do not utilize Bax-type signaling. 
Correspondingly, their IMS proteome of 49 proteins is considerably smaller than our IMS 
proteome of 127 proteins. Of their 49 yeast proteins, 35 have human orthologs. Of these, 18 
were detected in our IMS proteome (column Y in tab 1 of Table S1). For the 17 proteins we 
did not detect, two are not expressed in HEK 293T (Sultan et al., 2008), and three are likely 
to be expressed at very low levels (Beck et al., 2011; Sultan et al., 2008). The others may be 
undetected because they are sterically shielded from biotinylation in the context of living 
cells, or they are not localized to the IMS in human cells.
The human IMS proteome produced by this study should have value for mitochondrial 
biologists. We identified 16 proteins not previously associated with mitochondria and 
confirmed by follow-up imaging and western blotting of purified mitochondria that nine are 
indeed mitochondrial (Fig. 3C and 3D). One of these, Stx17, was shown by EM imaging to 
be enriched at mitochondria-ER contact sites (Fig. 4A and 4B). In addition, we assigned 21 
mitochondrial proteins not previously known to be IMS-localized to the IMS (tab 3 of Table 
S2). Finally, our data suggest that a key regulator of mitochondrial calcium uptake, MICU1 
(Fig. 4C), resides in the IMS. Our detection of endogenous MICU1 in the IMS helps to 
explain how it responds to cytosolic calcium levels to control the activity of the 
mitochondrial calcium uniporter MCU.
From a methodological perspective, our study establishes that APEX can be used to map 
cellular proteomes, even in the absence of a tight membrane barrier, with a spatial resolution 
on the order of ~5 nm (the distance between proteins inside the IMS and proteins just 
outside the OMM). With the ratiometric tagging approach, it will be interesting and valuable 
in future studies to map cellular proteomes that are even less understood and more 
challenging than the IMS, such as the outer mitochondrial membrane and mitochondria-ER 
contact sites.
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Experimental Procedures
SILAC labeling and biotinylation of the IMS proteome
Figures S2A and 2B show the experimental configurations for the 2-state and 3-state SILAC 
experiments, respectively. On day 0, early passage HEK 293T cells were seeded into three 
T25 flasks and cultured in SILAC media to metabolically label their proteomes with heavy, 
medium, or light isotopes of lysine and arginine (Ong et al., 2002). The media consisted of 
different isotopes of L-arginine and L-lysine in 10% dialyzed fetal bovine serum (Sigma), 
penicillin, streptomycin, glutamine, and 4.5 g/L glucose in DMEM (Caisson Laboratories). 
The first flask was cultured in light SILAC media, which contained L-arginine (Arg0) and 
L-lysine (Lys0) (Sigma). The second flask was cultured in heavy SILAC media, which 
contained L-arginine-13C6, 15N4 (Arg10) and L-lysine-13C6, 15N2 (Lys8) (Sigma). The third 
flask was cultured in medium SILAC media, which contained L-arginine [13C6]HCl (Arg6) 
and L-lysine-4,4,5,5-d4 (Lys4) (Sigma). The cells were split into fresh SILAC media every 
two days before they became fully confluent. On day 4, the cultures were expanded into T75 
flasks. After two more passages, the cultures were expanded into T150 flasks on day 10 as 
follows: three T150 flasks in heavy SILAC media (labeled H1, H2, and H3), one T150 flask 
in medium SILAC media (labeled M3), and four T150 flasks in light SILAC media (labeled 
L1, L2, L3, L4).
On day 11, the H1, H2, H3, L2, L3, and L4 cultures were transfected with 15 μg IMS-APEX 
plasmid using 120 μL Lipofectamine 2000 (Invitrogen) in 30 mL heavy or light DMEM 
without serum or antibiotics. The M3 flask was similarly transfected with 15 μg APEX-NES 
using medium DMEM. After four hours, the transfection solution was replaced with fresh 
SILAC media, and the cells were allowed to recover for 24 hours.
Cells were labeled on day 12. The H1, H2, M3, L1, L3, and L4 cultures were incubated with 
500 μM biotin-phenol in 40 mL SILAC media for 30 minutes at 37 °C. Then, H2O2 was 
added to a final concentration of 1 mM for 1 minute at room temperature, after which the 
probe/H2O2 solution was replaced with 15 mL of “quencher solution” (10 mM sodium 
ascorbate, 10 mM sodium azide, and 5 mM Trolox in Dulbecco’s Phosphate Buffered Saline 
(DPBS)). All samples, including the L2 flask (negative control with biotin-phenol and H2O2 
omitted), were washed twice with the quencher solution, twice with DPBS, and once more 
with the quencher solution. Each wash volume was 15 mL. The cells were then collected in 
5 mL of quencher solution by gentle pipetting and pelleted at 500×g for 3 minutes at room 
temperature. After discarding the supernatant, the cell pellet was stored at −80 °C overnight.
Cell pellets were thawed on ice and then lysed with 800 μL of freshly-prepared, ice-cold 
RIPA lysis buffer (50 mM Tris, 150 mM NaCl, 0.1% SDS, 0.5% sodium deoxycholate, 1% 
Triton X-100, 1× protease inhibitor cocktail (Sigma Aldrich catalog no. P8849), 1 mM 
PMSF (phenylmethylsufonyl fluoride), 10 mM sodium azide, 10 mM sodium ascorbate, and 
5 mM Trolox) by gentle pipetting. The lysates were centrifuged at 13,000 rpm for 10 
minutes at 4 °C, and the protein concentrations of the clarified lysates were measured using 
a Pierce 660 nm Protein Assay kit, with freshly-made bovine serum albumin solutions as 
standards.
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Streptavidin enrichment and elution of biotinylated proteins
Figures S2A and 2B, in addition to the Table under “In-gel digestion of biotinylated 
proteins, extraction, liquid chromatography, and mass spectrometry” in the Supplemental 
Experimental Procedures, summarize how the lysates for each SILAC culture were 
combined. The 2-state Replicate 1 sample consisted of H1 and L1 mixed in a 1:1 ratio (by 
protein concentration). The 2-state Replicate 2 sample consisted of H2 and L2 mixed in a 
1:1 ratio. The 3-state sample consisted of H3, M3, and L3 mixed in a 1:1:1 ratio. Each 
sample had a total of at least 2.6 mg protein (at 2–4 mg/mL protein concentration). In 
addition, L4 lysate was spiked in at 5% (by protein concentration) to each sample to 
facilitate quantitation of isotope ratios.
Streptavidin-coated magnetic beads (Pierce) were washed twice with RIPA lysis buffer. 
Each sample was mixed with 500 μL of streptavidin bead slurry. The suspensions were 
gently rotated at room temperature for 1 hour to bind biotinylated proteins. The flow-
through after enrichment was removed and stored at 4 °C, and the beads were washed with 2 
× 1 mL RIPA lysis buffer, 1 mL of 2 M urea in 10 mM Tris-HCl pH 8.0, and again with 2 × 
1 mL RIPA lysis buffer. These denaturing washes are important to break protein-protein 
interactions and ensure enrichment only of proteins directly biotinylated by APEX. 
Biotinylated proteins were then eluted by heating the beads at 95 °C for 5 minutes in 60 μL 
1× NuPAGE LDS Sample Buffer (Invitrogen) supplemented with 20 mM DTT and 2 mM 
biotin. A second round of enrichment was completed on the flow-through from the 3-state 
SILAC experiment (following the same protocol) because the first round of enrichment did 
not yield sufficient protein.
Further processing of the biotinylated proteins into samples for mass spectrometry and all 
other experimental procedures are provided in the Supplemental Experimental Procedures.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Highlights
• Ratiometric tagging with an engineered peroxidase gives nanometer spatial 
resolution
• Mitochondrial intermembrane space proteome mapped with >94% specificity
• 9 novel mitochondrial proteins confirmed by follow-up imaging and western 
blotting
• Data support MICU1 and MICU2 localization in the mitochondrial 
intermembrane space
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Figure 1. 
APEX-based proteomic mapping scheme and characterization of IMS-APEX labeling. (A) 
Scheme. APEX (green pacman) is targeted to the intermembrane space (IMS) of HEK 293T 
cells by genetic fusion to the leader sequence of the IMS protein LACTB (Polianskyte et al., 
2009). The IMS and matrix subcompartments of the mitochondrion are labeled in blue, in 
addition to the outer mitochondrial membrane (OMM) and inner mitochondrial membrane 
(IMM). To initiate proteomic tagging, H2O2 is added to live cells for 1 minute in the 
presence of biotin-phenol (red B = biotin). APEX catalyzes the generation of biotin-
phenoxyl radicals, which tag proximal endogenous proteins. Cells are then lysed, and tagged 
proteins are enriched with streptavidin beads and identified by mass spectrometry. Due to 
the porosity of the OMM (porins allow passage of molecules <5 kD (Herrmann and Riemer, 
2010)), IMS-APEX can tag some cytosolic proteins outside mitochondria, giving unwanted 
background. This study reports a new ratiometric method to eliminate this background. The 
enlarged box at right shows one possible structure of the biotin-phenol adduct with a 
tyrosine side chain. Other adduct structures, including with other amino acids, are likely to 
be formed as well. (B) EM characterization of IMS-APEX localization. HEK 293T cells 
expressing IMS-APEX were fixed and then overlaid with a solution of diaminobenzidine 
(DAB) and H2O2. APEX catalyzes the oxidation of DAB to generate a locally-deposited 
DAB polymer (Martell et al., 2012). After staining the polymer with electron-dense OsO4, 
the sample was imaged by EM. For comparison, APEX targeted to the mitochondrial matrix 
(Rhee et al., 2013) is shown on the right. Scale bars, 100 nm. (C) Streptavidin blot analysis 
of endogenous proteins tagged by IMS-APEX. Samples were transfected with IMS-APEX 
or cytosolic APEX-NES (NES = nuclear export sequence) and labeled for 1 minute as in 
(A). Afterwards, cells were lysed, run on gel, and analyzed by streptavidin blotting (left) and 
Ponceau staining (right). Negative controls are shown with biotin phenol (BP) omitted (lanes 
2 and 5) or H2O2 omitted (lanes 3 and 6). Lane 7 shows untransfected cells. The band near 
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80 kD contains the endogenously biotinylated proteins 3-methylcrotonyl-CoA carboxylase 
and propionyl-CoA carboxylase (Chandler and Ballard, 1986). (D) Fluorescence imaging of 
IMS-APEX labeling in cells. HEK 293T cells were transfected with IMS-APEX, matrix-
APEX, or APEX-NES and labeled live as in (A). Cells were then fixed and stained with 
neutravidin to visualize biotinylated proteins, and anti-V5 or anti-Flag antibody to visualize 
APEX localization. The anti-V5/Flag channel is not normalized. Scale bars, 20 μm.
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Figure 2. 
Ratiometric APEX tagging strategy improves spatial specificity and produces a high quality 
IMS proteome. (A) Because the OMM is permeable to molecules <5 kDa, including the 
biotin-phenoxyl radical, some cytosolic proteins will be tagged by IMS-APEX. However, it 
is possible to distinguish IMS proteins (e.g., protein 1, represented by the black box) from 
cytosolic proteins (e.g., protein 2) by comparing each protein’s extent of biotinylation by 
IMS-APEX (left) versus cytosolic APEX (APEX-NES) (right). For example, protein 1 
should be more strongly biotinylated by IMS-APEX than by APEX-NES, regardless of its 
steric accessibility or surface tyrosine count. Conversely, protein 2 should be tagged more 
extensively by APEX-NES than by IMS-APEX. Red coloring represents endogenous 
proteins biotinylated by APEX. (B) 3-State SILAC experimental setup. Three HEK 293T 
cultures were treated identically with biotin-phenol and H2O2 for 1 minute, but the heavy 
culture expressed IMS-APEX, the medium culture expressed APEX-NES, and the light 
culture was untransfected. After labeling, the three lysate samples were combined and 
processed together as shown. For each protein, the H/L SILAC ratio reflects the extent of its 
biotinylation by IMS-APEX. The M/L SILAC ratio reflects the extent of its biotinylation by 
APEX-NES. The H/M SILAC ratio reflects the ratio of that protein’s biotinylation by IMS-
APEX versus APEX-NES. (C) Scatter plot showing H/L ratio plotted against M/L ratio for 
99.96% of the 4,868 proteins identified by MS (inset shows all proteins, including the few 
with very low SILAC ratios). Proteins previously known to be IMS-exposed are colored 
green in the plot (i.e., true positives, defined as members of our “IMS gold+ list” (tab 1 of 
Table S2)). Proteins without previous mitochondrial annotation are colored red (false 
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positives). SILAC cut-offs used in row 4 of (D) are shown by the dashed lines. See “Scatter 
plot analysis” in the Supplemental Experimental Procedures and tab 5 of Table S1 for 
details. (D) Table showing IMS proteome size, specificity, and coverage derived from 
different datasets and different SILAC cut-offs (truncated to three significant figures). 
Specificity refers to mitochondrial specificity, i.e. the percentage of the proteome that has 
mitochondrial annotation in GOCC (Ashburner et al., 2000), Mitocarta (Pagliarini et al., 
2008), our previous mitochondrial matrix proteome (Rhee et al., 2013), or the literature. 
Coverage refers to the percentage of our IMS gold+ list (tab 1 of Table S2) that is detected 
in the proteome. Condition 5 (bottom row, colored blue) was used to obtain the final IMS 
proteome (shown in tab 1 of Table S1). Rep1 and Rep2 are the two different replicates of the 
2-state SILAC experiment described in Figure S2A.
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Figure 3. 
Characterization of IMS proteome specificity. (A) Bar graph showing the enrichment of 
mitochondrial proteins as well as IMS proteins in the IMS proteome. The first two columns 
show the percentage of proteins, in the entire human proteome and in the IMS proteome, 
respectively, with prior mitochondrial annotation. The second two columns show the 
percentage of proteins with potential IMS exposure (IMS, IMM, or OMM annotation). 
*mito proteins refers to the 579 mitochondrial proteins with annotated sub-mitochondrial 
localization. See tab 4 of Table S2 for details. (B) Subunits of the TOM/TIM/PAM 
mitochondrial protein import complex (Gebert et al., 2011) detected in the IMS proteome 
(left) and in our previous mitochondrial matrix proteome (right) (Rhee et al., 2013). See tab 
5 of Table S2 for details. (C) Imaging analysis of six mitochondrial orphans identified in 
this study. After transient transfection, proteins were detected by anti-V5 staining in COS-7 
cells, and compared to a mitochondrial GFP marker. Regions of overlap are colored yellow 
in the “merge” row. Quantitation of overlap from ≥10 cells for each protein is given beneath 
each image set. A positive control construct (IMS-APEX) gave 89.3% ± 6.3% mitochondrial 
overlap, while negative control constructs (P4HB-V5 and APEX-NES) gave 40.3% ± 9.9% 
and 27.0% ± 9.0% mitochondrial overlap, respectively (data not shown). Scale bars, 10 μm. 
Note that imaging experiments for individual orphans were performed separately, rather 
than in parallel, but are shown together here. (D) Western blot detection of three 
mitochondrial orphans identified in this study, in purified mouse liver mitochondria. WTL is 
whole tissue lysate. Protein molecular weights are 110 kD (NBR1), 65 kD (FKBP10), and 
50 kD (CDC25C). Control blots are shown for a mitochondrial matrix marker (ATP5B, 51 
kD), which becomes enriched as mitochondrial purity increases, and an ER marker 
(calreticulin, 48 kD), which becomes de-enriched.
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Figure 4. 
Localization analysis of Stx17 and MICU1. (A) EM imaging of syntaxin 17 (Stx17) with an 
APEX2 tag (Lam et al., submitted) fused to its N-terminus. HEK 293T were transduced with 
APEX2-Stx17 lentivirus, then processed as in Figure 1B. DAB staining (arrowheads) is 
observed at junctions between mitochondria (M) and endoplasmic reticulum (ER) tubules. 
Scale bars, 200 nm. (B) Cartoon illustrating possible arrangement of Stx17 molecules at 
starred mitochondria-ER contact site in (A). Stx17 is a SNARE-type protein with two 
transmembrane domains and N- and C-termini that face the cytosol (Itakura et al., 2012). 
Based on the DAB staining pattern in (A), we propose that Stx17 resides in both OMM and 
ER membranes with its N-terminus facing the cytosol. For the OMM pool, the hairpin loop 
joining the two transmembrane domains would contact the IMS, explaining the detection of 
Stx17 in our IMS proteome. (C) Known components of the mitochondrial calcium uniporter 
(MCU) complex are depicted at left (Sancak et al., 2013). In the table at right, for each 
protein of this complex, the corresponding IMS proteome (3-state experiment) and matrix 
proteome (replicate 1) SILAC values are listed. n.d. indicates not detected. Grey-shaded 
values were below the cut-offs for inclusion in IMS or matrix proteomes. Red-shaded values 
were above the cut-offs for inclusion in the IMS proteome. See tab 7 of Table S2 for details.
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